199 related articles for article (PubMed ID: 2313939)
1. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine.
Motomura S; Hashimoto K
Jpn J Pharmacol; 1990 Feb; 52(2):319-30. PubMed ID: 2313939
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
Satoh K; Yanagisawa T; Taira N
Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists.
Ohtsuka M; Ono T; Hiroi J; Esumi K; Kikuchi H; Kumada S
J Cardiovasc Pharmacol; 1983; 5(6):1074-82. PubMed ID: 6196557
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.
Wada Y; Satoh K; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):382-7. PubMed ID: 2581147
[TBL] [Abstract][Full Text] [Related]
5. Lacidipine, a new long-acting dihydropyridine calcium antagonist, has high vascular selectivity against all intracardiac variables.
Motomura S; Wu ZJ; Hashimoto K
Heart Vessels; 1993; 8(1):16-22. PubMed ID: 8454559
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
Takahashi K; Taira N
Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
Orito K; Satoh K; Taira N
J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
[TBL] [Abstract][Full Text] [Related]
8. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
Wada Y; Satoh K; Taira N
J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
[TBL] [Abstract][Full Text] [Related]
9. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
Wada Y; Satoh K; Taira N
J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
[TBL] [Abstract][Full Text] [Related]
10. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
Imagawa J; Satoh K; Taira N
Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
[TBL] [Abstract][Full Text] [Related]
11. Effects of nicardipine, a dihydropyridine calcium antagonist, on regional myocardial blood flow, myocardial oxygen tension, and electrical abnormalities during acute coronary artery occlusion in dogs.
Hashimoto H; Asano M; Takiguchi Y; Katoh H; Nakashima M
J Cardiovasc Pharmacol; 1985; 7(4):613-21. PubMed ID: 2410698
[TBL] [Abstract][Full Text] [Related]
12. In-vitro negative chronotropic and inotropic effects of a novel dihydropyridine derivative, CD-832, in the guinea-pig: comparison with calcium-channel antagonists.
Noguchi K; Takahashi K; Higuchi S
J Pharm Pharmacol; 1998 Mar; 50(3):329-34. PubMed ID: 9600727
[TBL] [Abstract][Full Text] [Related]
13. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
Nakaya H; Hattori Y; Nakao Y; Kanno M
Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
[TBL] [Abstract][Full Text] [Related]
14. Are the cardiovascular effects of gentamicin similar to those of calcium antagonists?
Gotanda K; Yanagisawa T; Satoh K; Taira N
Jpn J Pharmacol; 1988 Jul; 47(3):217-27. PubMed ID: 3221528
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
Satoh K; Wada Y; Taira N
Arzneimittelforschung; 1986; 36(1):35-9. PubMed ID: 2937413
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
17. Effects of S-312, a new calcium antagonist, on the mechanical and electrophysiological responses of isolated cardiovascular preparations.
Ninomiya M; Tani T; Nakajima S; Ueda M
Jpn J Pharmacol; 1989 Oct; 51(2):227-38. PubMed ID: 2593380
[TBL] [Abstract][Full Text] [Related]
18. Differences in cardiovascular profile among calcium antagonists.
Taira N
Am J Cardiol; 1987 Jan; 59(3):24B-29B. PubMed ID: 3544789
[TBL] [Abstract][Full Text] [Related]
19. Effects of Bay k 8644 on the coronary vascular selectivity of the dihydropyridine Ca antagonists in the canine isolated, blood-perfused papillary muscle preparation.
Motomura S; Hashimoto K; Hashimoto K
J Cardiovasc Pharmacol; 1987 Dec; 10(6):627-35. PubMed ID: 2450231
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations.
Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
J Cardiovasc Pharmacol; 2000 May; 35(5):741-8. PubMed ID: 10813376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
